MedPath

The Effect of Roux-en-Y Gastric Bypass on Mitochondrial Function in Type 2 Diabetes

Conditions
Type 2 Diabetes
Obesity
Registration Number
NCT01468116
Lead Sponsor
Hvidovre University Hospital
Brief Summary

Roux-en-Y gastric bypass (RYGB) surgery induces resolution of type 2 diabetes, often within days after surgery and before significant weight loss. The aim of this study is to investigate whether changes in mitochondrial function contributes to the early improvement of type 2 diabetes after RYGB.

Detailed Description

Mitochondrial dysfunction has been linked to development of insulin resistance in the muscle and hence to the pathogenesis of type 2 diabetes. Mitochondrial function can be studied non-invasively by 31 Phosphor Magnetic Resonance spectroscopy (31PMRS). In this study we will investigate changes in mitochondrial function using the combination of 31 PMRS and Near Infra-Red Spectroscopy (NIRS) after gastric bypass.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients eligible for gastric bypass surgery or cholecystectomy
  • Verified type 2 diabetes or normal glucose tolerance by OGTT
Exclusion Criteria
  • Patients unable to fit the dimensions of the MRI-scanner

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hvidovre University Hospital

🇩🇰

Copenhagen, Hvidovre, Denmark

© Copyright 2025. All Rights Reserved by MedPath